You just read:

Compugen Announces Presentations of COM701 Immuno-oncology Pipeline Product and Predictive Discovery Methodology for Novel Immune Checkpoints at AACR

News provided by

Compugen Ltd.

Mar 02, 2017, 07:00 ET